News

Researchers are making great strides toward developing gene-based strategies to treat a variety of inherited neurometabolic diseases characterized by severe neurological involvement.

A new study from the IKBFU laboratory suggests that alder bark may become a novel source of anti-aging and anti-disease natural antioxidants.

A newly identified set of three antibodies could lead to improved treatments and vaccines against influenza, according to new research published this week.

There is currently no approved vaccine for the Lassa arenavirus, which causes Lassa fever. This hemorrhagic fever, endemic in West Africa, infects up to 300,000 people each year. Now, researchers have identified a promising vaccine that is set to enter clinical testing in humans as soon.

In an historic announcement on World Polio Day, an independent commission of experts concluded that wild poliovirus type 3 (WPV3) has been eradicated worldwide. Following the eradication of smallpox and wild poliovirus type 2, this news represents a historic achievement for humanity.

A scientist from the Centre de recherche de l'Hôpital Maisonneuve-Rosemont and Université de Montréal, has uncovered a new cell therapy method that boosts the immune response of T lymphocytes to malignant tumors.

In a study published in Science Advances, researchers from East China Normal University have created an elegant system for activating genetically edited cells using green tea.

British Columbia’s school-based human papillomavirus (HPV) immunization program is reducing rates of cervical pre-cancer in B.C. women, according to a new study.

Not-for-profit Jisc and the Microbiology Society announce a pilot transitional open access agreement. The "Publish and Read" deal will allow researchers at participating institutions to publish an unlimited number of open-access articles, as well as access to the society’s full portfolio in return for a cost neutral fixed fee.

Synthetic bone substitutes are promising materials for bone defect repair, but their efficacy can be substantially improved by bioactive agents such as growth factors. In a new study, researchers have modified beta-tricalcium phosphate (β-TCP) with increasing quantities of bone morphogenetic protein 2 (BMP-2) derived from E. coli and shown improved bone healing.